Staying Conversational with Diabetes Monitoring in Community Pharmacy (Marquette A-B, Level 5)
112-00-10-122-L01-P & 112-000-10-822-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Gregg S. Potter, R.Ph., Ph.D., professor of pharmacology, Ferris State University College of Pharmacy, Big Rapids, Mich.
At the end of this presentation, participants should be able to list the current diagnostic tests involved in monitoring coronary heart disease and anticoagulation therapy and provide examples of new and upcoming diagnostic tests leading to better management of coronary heart disease. Participants should also be able to describe the relevance in monitoring fasting blood glucose, post-prandial blood glucose, hemoglobin A1c and ketones as monitoring parameters in diabetes mellitus patients.

Cleaning Your Karma: The How, What and Why of Pharmacist Volunteering (LaSalle A-B, Level 5)
112-000-10-123-L04-P & 112-000-10-823-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Jill A. Covyeou, Pharm.D., assistant professor, Ferris State University College of Pharmacy, Essexville, Mich.
At the end of this presentation, participants should be able to identify a volunteer clinic in their community that they could work with; describe a service that they would be able to provide to that clinic; and begin to construct a personal philosophy of service.

Medication Disposal in Michigan: Is There a Better Way? (Cadillac A-B, Level 5)
112-000-10-124-L04-P & 112-000-10-824-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Chris Angel, president, volunteer board of directors, Great Lakes Clean Water Organization, Barton City, Mich.; Gregory Baise, pharmacist, Knight Drugs, Livonia, Mich.; and Larry D. Wagenknecht, R.Ph., chief executive officer, Michigan Pharmacists Association, Lansing, Mich.
At the end of this presentation, participants should be able to explain the reasons why proper disposal of medications is important to the environment; discuss the recommended method of medication disposal; discuss the current laws related to the disposal of controlled substances and noncontrolled medications; and explain the advantages and disadvantages of successful medication disposal programs.

Medicare Update (Ambassador Ballroom 1, Level 3)
112-000-10-125-L03-P & 112-000-10-825-L03-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Todd Stankewicz, R.Ph., MBA, MPH, regional pharmacist, Centers for Medicare & Medicaid Services, Chicago, Ill.
At the end of this presentation, participants should be able to define the enhancements occurring in 2010 with the Medicare Prescription Drug Benefit; perform the proper submission of Limited Income NET claims; assist beneficiaries with working through the Part D appeals and grievance process; and identify the resources available to pharmacists to facilitate understanding of the Medicare Part D drug benefit. (This program meets pharmacy law continuing education requirements for pharmacy technicians.)

Keynote Session Personalized Electronic Health Records (Ambassador Ballrooms 2-3, Level 3)
112-000-10-119-L04-P & 112-000-10-819-L04-T, 1.0 contact hour
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Bill G. Felkey, MS, professor emeritus, Auburn University’s Harrison School of Pharmacy, Auburn, Ala.
At the end of this presentation, participants should be able to determine the major components that make up the electronic health record; discuss the role of pharmacy as a profession in participatory health care; determine at least three connectivity opportunities that can be immediately adopted in their practice; and evaluate the positive benefits associated with advocacy of personal health records for all parties concerned.

Making Sense of Today's Regulatory Environment: A Primer on Fraud, Waste and Abuse, HIPAA and Red Flag Rules (Marquette A-B, Level 5)
112-000-10-126-L03-P & 112-000-10-826-L03-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Mark A. McAndrew, partner, Dinsmore & Shohl LLP, Cincinnati, Ohio
At the end of this presentation, participants should be able to recall federal laws that pertain to Medicare fraud, waste and abuse, HIPAA and Red Flag Rules and identify potential risk areas for pharmacies billing Medicare Part D plans. Participants should also be able to specify steps pharmacies can take to prevent fraud, waste and abuse and identify potential HIPAA privacy issues and Red Flag Rule compliance.

Assessing the Complex Senior Patient: Hip Fracture Part 1 – Preventing Venous Thromboembolism Following Hip Fractures (LaSalle A-B, Level 5)
112-000-10-127-L01-P & 112-000-10-827-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Sheila M. Wilhelm, Pharm.D., BCPS, assistant professor, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Mich.
At the end of this presentation, participants should be able to describe normal hip anatomy, common types of hip fracture and surgical options for hip fracture repair; explain the pathogenesis of venous thromboembolism (VTE) in hip fracture; and compare available anticoagulants for VTE prevention post-hip fracture. Participants should also be able to design and monitor a patient-specific, evidence-based plan for VTE prophylaxis after hip fracture and describe future pharmacologic options for the prevention of VTE after hip fracture.

Health Information Exchange – A Solution to Improving Care
(Cadillac A-B, Level 5)
112-000-10-128-L04-P & 112-000-10-828-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Larry D. Wagenknecht, R.Ph., chief executive officer, Michigan Pharmacists Association, Lansing, Mich.
At the end of this presentation, participants should be able to discuss the status of health information exchange (HIE) in the state of Michigan; explain the role of the pharmacist in HIE; and discuss ways in which HIE will improve patient safety.

Wut duz ur profile say about u? The Potential Impact of the Internet and Social Networks on Your Career (Richard A-B, Level 5)
112-000-10-129-L04-P & 12-000-10-829-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Mary DelMonte, Pharm.D., pharmacy resident, University of Michigan College of Pharmacy, Ann Arbor, Mich.; Michael D. Kraft, Pharm.D., BCNSP, clinical associate professor, University of Michigan College of Pharmacy, Ypsilanti, Mich.
At the end of this presentation, participants should be able to identify and illustrate various methods of communication utilized by student pharmacists, pharmacy technicians and pharmacists, and describe and analyze the potential benefits and concerns regarding the use of e-mail, the Internet and other social networking Web sites, blogs and other online/electronic media relating to professional pharmacy practice. Participants should also be able to develop some guidelines or best practices for the use of e-mail, the Internet and other electronic communication tools relating to professional pharmacy practice and professional development; and discuss the potential future uses of online resources in the pharmacy profession relating to professional practice and professional development.

Smart Financial Decisions Today for the Pharmacists of Tomorrow
(Nicolet A-B, Level 5)
Continuing education credit will not be awarded for this program.
Reuben Levinsohn, director, Centennial Medical Team, and financial advisor, investment specialist, The Centennial Group, Lansing, Mich.; and Kirk Sempsrott, financial advisor, investment specialist, Centennial Medical Team, Lansing, Mich.
The financial game is changing in front of our eyes and it is becoming more challenging than ever. Now is the time to learn how you can play the game better in the midst of a major housing market slump, a volatile stock market, a major credit and lending crisis, rising unemployment and health care reform. This may sound scary, but it could be an unbelievable opportunity for those who will learn and implement the five strategies that you will learn during this presentation.

Glaucoma and Macular Degeneration: Pathophysiology and Treatment (Marquette A-B, Level 5)
112-000-10-130-L01-P & 112-000-10-830-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity Dean L. Luplow, OD, optometrist, Michigan College of Optometry, Ferris State University, Big Rapids, Mich.
At the end of this presentation, pharmacists should be able to discuss the pathophysiology of the various categories of glaucoma and macular degeneration; discuss the classes of medications and the specific medications used to treat glaucoma in relationship to the mechanism causing each type of glaucoma; and identify the limitations of treatment of macular degeneration with prescription and over-the-counter medications in the context of the present state of knowledge of macular degeneration.

Assessing the Complex Senior Patient: Hip Fracture: Part 2 – Inpatient and Outpatient Osteoporosis Treatment (LaSalle A-B, Level 5)
112-000-10-131-L01-P & 112-000-10-831-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Application-based Activity
Mary Beth O’Connell, Pharm.D., BCPS, FASHP, FCCP, associate professor, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Mich.
At the end of this presentation, participants should be able to design an osteoporosis treatment program for inpatient and outpatient therapy after a fragility fracture; interpret and utilize FRAX and DXA results; apply the National Osteoporosis Foundation osteoporosis guidelines to patient care; and utilize inpatient and outpatient osteoporosis quality and performance standards to evaluate systems of care.

NASPA-NMA Self-care Championship (Ambassador Ballrooms 2-3, Level 3)
112-000-10-133-L01-P & 112-000-10-833-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Application-based Activity
Competing Teams to be Announced
At the end of this presentation, participants should be able to identify and explain aspects of the effective and safe practice of pharmacy self-care treatments; analyze the usage and effectiveness of over-the-counter medications; and classify different groups of over-the-counter medications based on drug treatment class.

New Drug Update 2010 (Cadillac A-B, Level 5)
112-000-10-132-L01-P & 112-000-10-832-L01-T, 2.8 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
H. Stephen Lee, Pharm.D., assistant professor of pharmacy practice, Ferris State University College of Pharmacy, Grand Rapids, Mich.; and Jacqueline A. Morse, Pharm.D., BCPS, assistant professor of pharmacy practice, Ferris State University College of Pharmacy, Grandville, Mich.
At the end of this presentation, participants should be able to identify medications that were FDA-approved within the last 12 months; describe indications, doses, formulations, adverse effects and drug interactions of recently approved medications; and discuss pertinent patient counseling points and monitoring parameters related to recently approved medications.

Hospital Quality and Safety (Marquette A-B, Level 5)
112-000-10-134-L04-P & 112-000-10-834-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Christine A. Rosey, Pharm.D., clinical coordinator, Bronson Methodist Hospital, Kalamazoo, Mich.; and Cherie L. Woodhams, R.Ph., pharmacy educator, Bronson Methodist Hospital, Kalamazoo, Mich.
At the end of this presentation, participants should be able to identify various institutes and organizations that focus efforts on improvements in outcomes for hospitalized patients, and explain how safety and quality initiatives are introduced and carried out at Bronson Methodist Hospital. Participants should also be able to discuss the role of a variety of departments in change initiatives and explain the importance of data collection and outcome data in the hospital’s overall reputation to the public.

Michigan Health Professional Recovery Program (LaSalle A-B, Level 5)
112-000-10-135-L04-P & 112-000-10-835-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Susan M. Bushong, LBSW, contract administrator, outreach coordinator, Health Professional Recovery Program, Michigan Department of Community Health, Bureau of Health Professions, Lansing, Mich.
At the end of this presentation, participants should be able to discuss resources for licensed health care professionals with substance abuse and/or mental health disorders, which may impair their ability to safely practice in their profession; discuss mandatory reporting requirements for health care professionals that may require treatment; and examine content of a recovery monitoring agreement and when a participant may return to their profession.

Federal (and Some Michigan) Pharmacy Law (Ambassador Ballroom 1, Level 3)
112-000-10-137-L03-P & 112-000-10-837-L03-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Jesse C. Vivian, R.Ph., J.D., professor, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Mich.
At the end of this presentation, participants should be able to discuss HIPAA privacy obligations and DEA diversion prevention mandates; review the new DEA provider registration letters scheme; review developments in electronic health records; and examine new HIPAA privacy breach self-reporting rules. Participants should be able to explain Locum Tenens rules; discuss Michigan out-of-state prescribing regulations; discuss drug repositories and future potentials; talk about mandatory dispensing case law and legislative developments; and discuss proposed changes in Michigan laws affecting pharmacy practice. (This program meets pharmacy law requirements for certified pharmacy technicians.)

2010 Pharmacy Law Review (Nicolet A-B, Level 5)
Continuing education credit will not be awarded for this program.
Audience: Student Pharmacists
Gregory J. Baran, R.Ph., director of governmental affairs, Michigan Pharmacists Association, Lansing, Mich.
This program was created to assist student pharmacists in preparing for the Multistate Pharmacy Jurisprudence Examination. Participants will receive either a book, “Michigan Pharmacy Law: A Guide to the Statutes and Regulations,” or the Pharmacy Law Update Service (PLUS) CD. Invitation only. Pre-registration is necessary. Presentation limited to student pharmacists only.

The Inside Perspective of Four Medication Therapy Management (MTM) Practice Models (Marquette A-B, Level 5)
112-000-10-138-L04-P & 112-000-10-838-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Betsy Davis, R.Ph., clinical pharmacist, MTM program manager, Blue Cross Blue Shield of Michigan, Southfield, Mich.; William A. Green, R.Ph., pharmacy consultant, Bill Green and Company, LLC, Scotts, Mich.; Brent Hubble, Pharm.D., manager, clinical program developer, Diplomat Pharmacy, Grand Rapids, Mich.; Hend Samaha, R.Ph., MTM pharmacist, Well Street Care Management™, Kalamazoo, Mich.; Jeffrey Rowe, R.Ph., senior vice president of operations, Diplomat Pharmacy, Flushing, Mich.; and Wendy Zundel, Pharm.D., disease state management pharmacist, Meijer, Inc., Dearborn Heights, Mich.
At the end of this presentation, participants should be able to identify MTM practice opportunities in their markets based upon the MTM models provided; compare and contrast the value each MTM model brings to the patient population it serves; describe the challenges and rewards of implementing an MTM practice; and discuss the opportunities that emerging trends in MTM service development affords pharmacists. The MSCP Pharmacist of the Year Award will also be presented during this session.

My Partner’s an Addict: What Do I Do? (LaSalle A-B, Level 5)
112-000-10-139-L04-P & 112-000-10-839-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Carl Christensen, MD, Ph.D., MRO, vice chair, Michigan Health Professional Recovery Corporation, Superior Twp., Mich.
At the end of this presentation, participants should be able to state two alternative theories of addiction; state two risk factors and three warning signs for addiction in a health care professional; identify the different presentations of patients with chronic pain and addiction; and explain the role of the Michigan Health Professional Recovery Program (HPRP) in diagnosing and treating addicted health care professionals.

Anticoagulation Therapy in Pediatrics (Brule A-B, Level 5)
112-000-10-140-L01-P & 112-000-10-840-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Application-based Activity
Regina N. Tamon, Pharm.D., pharmacy practice resident, Children’s Hospital of Michigan, Novi, Mich.
At the end of this presentation, participants should be able to discuss the common indications for pediatric anticoagulation therapy; identify the primary differences in anticoagulation therapy between pediatric and adult populations; describe how to safely and effectively initiate and maintain pediatric patients on anticoagulation therapy; and identify opportunities for pharmacist involvement in the management of pediatric anticoagulation, and based on a specific patient case, recommend appropriate therapy.

Treatment for Fibromyalgia: Hope or Hype? (Ambassador Ballroom 1, Level 3)
112-000-10-141-L01-P & 112-000-10-841-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Kierstan M. Hanson, Pharm.D., assistant professor, Ferris State University College of Pharmacy, East Lansing, Mich.
At the end of this presentation, participants should be able to list common symptoms of fibromyalgia and describe the importance of coexisting disorders; discuss possible pathologic causes of fibromyalgia; evaluate the evidence in order to compare and contrast available treatment options; and, based on specific patient case, recommend appropriate therapy. (This program meets requirements for obtaining pain management continuing education credit for pharmacists.)